https://www.selleckchem.com/pr....oducts/leupeptin-hem
34±10.98mmHg; p=0.006; day 90 41.62±10.88mmHg; p=0.011). Skin dryness and shedding showed an improvement from baseline to the end of the study in both groups, secondary to the use of the tested emulsion (p0.001 and p0.001, respectively). Skin colour also showed differences from baseline to the final visit in the neuroischaemic patients (p=0.029). Patients with neuropathy did not show any change in skin colour from baseline to the final visit. Analysis of the use of the tested emulsion showed an increase in TcPO and
Like
Comment
Share
